Salvia divinorum and Salvinorin A: New Pharmacologic Findings.
by Daniel Siebert. Journal of Ethnopharmacology. 43: 53–56 (1994). This paper is in PDF format. |
Localization of Salvinorin A and Related Compounds in Glandular Trichomes of the Psychoactive Sage, Salvia divinorum.
by Daniel Siebert. Annals of Botany 93(6): 763–771 (2004). This paper is in PDF format.
|
High Performance Liquid Chromatographic Quantification of Salvinorin A from Tissues of Salvia divinorum Epling & Játiva-M.
by Gruber JW, Siebert DJ, Der Marderosian AH, and Hock RS. Phytochemical Analysis 10(1):22–25 (1999). |
Salvinorin A: A Potent Naturally Occurring Nonnitrogenous Kappa Opioid Selective Agonist.
by Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, and Rothman RB.
PNAS. 99(18): 11934–11939 (2002). This document is in PDF format.
Supporting information: table 3, table 4, table 5.
|
Salvinorin A, an Active Component of the Hallucinogenic Sage Salvia divinorum, is a Highly Efficacious
Kappa Opioid Receptor Agonist: Structural and Functional Considerations.
by Chavkin C, Sud S, Jin W, Stewart J, Zjawiony JK, Siebert DJ, Toth BA, Hufeisen SJ, and Roth BL.
The Journal of Pharmacology and Experimental Therapeutics. 308(3): 1197–1203 (2004). This document is in PDF format.
|
Comparison of Pharmacological Activities of Three Distinct Kappa-Ligands (Salvinorin A, TRK-820 and 3FLB)
on opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.
by Wang Y, Tang K, Inan S, Siebert DJ, Holzgrabe U, Lee DYW, Huang P, Li JG, Cowan A, and Liu-Chen LY.
The Journal of Pharmacology And Experimental Therapeutics. 312(1): 220–230 (2005).
|
2-Methoxymethyl-Salvinorin B is a Potent Kappa Opioid Receptor Agonist with Longer Lasting Action In Vivo than Salvinorin A.
by Wang Y, Chen Y, Xu W, Lee DY, Ma Z, Rawls SM, Cowan A, Liu-Chen LY.
The Journal of Pharmacology And Experimental Therapeutics. 324(3): 1073-1083.
|
The Hallucinogenic Herb Salvia divinorum and Its Active Ingredient Salvinorin A Inhibit Enteric Cholinergic Transmission in the Guinea Pig Ileum.
by Capasso R, Borrelli F, Capasso F, Siebert DJ, Stewart DJ, Zjawiony JK, Izzo AA.
Neurogastroenterology and Motility. 18: 69–75 (2006).
|
The Hallucinogenic Herb Salvia divinorum and Its Active Ingredient Salvinorin A Reduce Inflammation-Induced Hypermotility in Mice.
by Capasso R, Borrelli F, Zjawiony J, Kutrzeba L, Aviello G, Sarnelli G, Capasso F, Izzo AA.
Neurogastroenterology and Motility. [Epub ahead of print Sep 4, 2007].
|
Antinociceptive and Hypothermic Effects of Salvinorin A are Abolished in a Novel Strain of KOR-1 KO Mice.
by Ansonoff MA, Zhang J, Czyzyk T, Rothman RB, Stewart J, Xu H, Zjwiony J, Siebert DJ, Yang F, Roth BL, Pintar JE.
The Journal of Pharmacology and Experimental Therapeutics. 318(2): 641-648 (2006).
|
Daniel Siebert Speaks…
Interviewed by Will Beifuss. The Entheogen Review. Vol. 8 No. 3, Autumn 1999. |
The History of the First Salvia divinorum Plants Cultivated Outside of Mexico.
by Daniel Siebert. The Entheogen Review. Vol. 12 No. 4, Winter 2003. |
Salvinorin A: The ‘Magic Mint’ Hallucinogen Finds a Molecular Target in the Kappa Opioid Receptor.
by Sheffler DJ and Roth BL. Trends in Pharmacological Sciences. Vol.24 No.3 March 2003. This review article is in PDF format.
|
Salvinorin A: A Novel and Highly Selective Kappa-Opioid Receptor Agonist.
by Yan F and Roth BL. Life Sciences. Vol.75 No.22 (2004). This review article is in PDF format.
|
Salvinorin A: From Natural Product to Human Therapeutics.
by Vortherms TA and Roth BL. Molecular Interventions. Vol.6 No.5 (2006). This review article is in PDF format.
|
Differential Helical Orientations Among Related G Protein-Coupled Receptors Provide a Novel Mechanism for Selectivity:
Studies with Salvinorin A and the Kappa-Opioid Receptor.
by Vortherms TA, Mosier PD, Westkaemper RB, Roth BL.
Journal of Biological Chemistry. 282(5): 3146–3156 (2007). This paper is in PDF format.
|
Acute Physiologic and Chronic Histologic Changes in Rats and Mice Exposed to the Unique Hallucinogen Salvinorin A.
by Mowry M, Mosher M, Briner W. Journal of Psychoactive Drugs. 35(3): 379–382 (2003). This paper is in PDF format.
|
The Plant-Derived Hallucinogen, Salvinorin A, Produces Kappa-Opioid Agonist-like Discriminative Effects in Rhesus Monkeys.
by Butelman E, Harris T, and Kreek MJ. Psychopharmacology (Berl). 172(2): 220–224 (2004). This paper is in PDF format.
|
Effects of Salvinorin A, a Kappa-Opioid Hallucinogen, on a Neuroendocrine Biomarker Assay
in Nonhuman Primates With High Kappa-Receptor Homology to Humans.
by Butelman ER, Mandau M, Tidgewell K, Prisinzano TE, Yuferov V, Kreek MJ.
Journal of Pharmacology and Experimental Therapeutics. 320(1): 300–306 (2007). This paper is in PDF format.
|
A New Species of Salvia from Mexico.
by Carl Epling and Carlos D. Játiva–M. Botanical Museum Leaflets Harvard University (1962). |
A New Mexican Psychotropic Drug From the Mint Family.
by R. Gordon Wasson. Botanical Museum Leaflets Harvard University (1962). |
Notes on the Present Status of Ololiuhqui and the Other Hallucinogens of Mexico.
by R. Gordon Wasson. Botanical Museum Leaflets Harvard University (1963). |
A Mazatec girl preparing Salvia divinorum leaves on a metate.
Photo taken in 1962 by R. Gordon Wasson. |
In Search of the Magic Plant "Ska Maria Pastora"
in the Mazatec Country.
by Albert Hofmann. From: LSD: My Problem Child (1979). |
Salvinorin, A New trans-Neoclerodane Diterpene from Salvia divinorum (Labiatae).
by Ortega A, Blount JF, Manchand PS. Journal of the Chemical Society Perkins Transactions I (1982). This document is in PDF format. |
Ethnopharmacology of Ska Maria Pastora (Salvia divinorum, Epling and Játiva-M.).
by L.J. Valdés J III, et al. Journal of Ethnopharmacology (1983). |
Etnofarmacologia di Ska Maria Pastora (Salvia divinorum, Epling and Játiva-M.) An Italian translation of the above. |
Divinorin A, a Psychotropic Terpenoid, and Divinorin B from the Hallucinogenic Mexican Mint, Salvia divinorum.
by L.J. Valdés III, et al. Journal of Organic Chemistry (1984). |
Loliolide from Salvia divinorum.
by L.J. Valdés III. Journal of Natural Products (1986). |
Studies of Salvia divinorum (Lamiaceae), an Hallucinogenic Mint from the Sierra Mazateca in Oaxaca, Central Mexico.
by L.J. Valdés III, et al. Economic Botany (1987). |
Salvia divinorum and the Unique Diterpene Hallucinogen, Salvinorin (Divinorin) A.
by L.J. Valdés III. Journal of Psychoactive Drugs (1994). |
"Divinorin C," a New Neoclerodane Diterpene from a Bioactive TLC Fraction of Salvia divinorum.
Lab notes from the desk of L. J. Valdés III. The Salvia divinorum Research and Information Center (2000). |
Salvinorin C, a New Neoclerodane Diterpene from a Bioactive Fraction of the Hallucinogenic Mexican Mint Salvia divinorum.
by L.J. Valdés III, et al. Organic Letters (2001). |
The Early History of Salvia divinorum.
by L. J. Valdés III. The Entheogen Review (2001) X(2): [73-75] |
Some photos of Salvia divinorum from the Sierra Mazateca. by L.J. Valdés III |
The Absolute Stereochemistry of Salvinorins. Also available in PDF format here.
by Koreeda, M., et al. Chemistry Letters (1990). |
Kappa-Opioid Receptor-Mediated Effects of the Plant-Derived Hallucinogen, Salvinorin A, on Inverted Screen Performance in the Mouse.
by Fantegrossi WE, Kugle KM, Valdés LJ III, Koreeda M, Woods JH.
Behavioural pharmacology. 16(8): 627-633 (2005). This document is in PDF format.
|
Salvinorins D-F, New Neoclerodane Diterpenoids from Salvia divinorum, and an Improved Method for the Isolation of Salvinorin A.
And supporting information. by Munro TA, Rizzacasa MA.
Journal of Natural Products. 66(5): 703-705 (2003). These two documents are in PDF format.
|
Divinatorins A-C, New Neoclerodane Diterpenoids from the Controlled Sage Salvia divinorum. And supporting information.
by Bigham AK, Munro TA, Rizzacasa MA, Robins-Browne RM.
Journal of Natural Products. 66(9): 1242-1244 (2003). These two documents are in PDF format.
|
Studies Toward the Pharmacophore of Salvinorin A, a Potent Kappa Opioid Receptor Agonist.
And supporting information.by Munro T, Rizzacasa M, Roth BL, Toth B, Yan F
Journal of Medicinal Chemistry. 48(2): 345–348 (2005). This document is in PDF format.
|
Autoxidation of Salvinorin A under Basic Conditions.
And supporting information.by Munro T, Goetchius G, Roth BL, Vortherms T, Rizzacasa M.
Journal of Organic Chemistry. 70(24): 10057-10061 (2005). This document is in PDF format.
|
8-epi-Salvinorin B: Crystal Structure and Affinity at the Kappa Opioid Receptor.
by Munro TA, Duncan KK, Staples RJ, Xu W, Liu-Chen LY, Beguin C, Carlezon WA Jr, Cohen BM.
Beilstein Journal of Organic Chemistry. Epub ahead of print (2007). This document is in PDF format.
|
The Chemistry of Salvia divinorum.
by Thomas Munro. PhD dissertation. This is a large (283 pages - 6.32 MB) document, in PDF format.
|
Standard Protecting Groups Create Potent and Selective Kappa Opioids: Salvinorin B Alkoxymethyl Ethers
by Munro TA, Duncan KK, Xu W, Wang Y, Liu-Chen LY, Carlezon WA Jr, Cohen BM, Beguin C.
Bioorganic and Medicinal Chemistry. 16(3): 1279-1286 (2008). This document is in PDF format.
|
Antidepressant Effects of the Herb Salvia divinorum: a Case Report.
by Karl R. Hanes, PhD. Journal of Clinical Psychopharmacology (2001). |
Salvia divinorum: Clinical and Research Potential.
by Hanes KR. MAPS Bulletin 13(1): 18–20 (2003). This paper is in PDF format.
|
Salvia divinorum and Salvinorin A: An Update on Pharmacology and Analytical Methodology.
by Grundmann O, Phipps SM, Zadezensky I, Butterweck V.
Planta Medica 73(10): 1039–1046 (2007). This paper is in PDF format.
|
Use of Nonprohibited Hallucinogenic Plants: Increasing Relevance for Public Health?
A case report and literature review on the consumption of Salvia divinorum (Diviner's Sage).
by Bücheler R, Gleiter CH, Schwoerer P, and Gaertner I.
Pharmacopsychiatry. 38(1): 1–5 (2005). This paper is in PDF format. |
A Facile Method for the Preparation of Deuterium Labeled Salvinorin A: Synthesis of [2,2,2-2H3]-Salvinorin A
by Kevin Tidgewell, Wayne W. Harding, Mark Schmidt, Kenneth G. Holden, Daryl J. Murry, and Thomas E. Prisinzano.
Bioorganic and Medicinal Chemistry Letters. 14(20): 5099-5102 (2004). This document is in PDF format.
|
Salvinicins A and B, New Neoclerodane Diterpenes from Salvia divinorum.
by Harding WW, Tidgewell K, Schmidt M, Shah K, Dersch CM, Snyder J, Parrish D, Deschamps JR, Rothman RB, Prisinzano TE.
Organic Letters. 7(14): 3017–3020 (2005). This document is in PDF format.
|
Neoclerodane Diterpenes as a Novel Scaffold for Mu Opioid Receptor Ligands.
by Harding WW, Tidgewell K, Byrd N, Cobb H, Dersch CM, Butelman ER, Rothman RB, Prisinzano TE.
Journal of Medicinal Chemistry. 48(15): 4765–4771 (2005). This document is in PDF format.
|
An Opioid Agonist That Does Not Induce Mu-Opioid Receptor–Arrestin Interactions or Receptor Internalization.
by Groer CE, Tidgewell K, Moyer RA, Harding WW, Rothman RB, Prisinzano TE, Bohn LM.
Molecular Pharmacology. 71(2): 549–557 (2007). This document is in PDF format.
|
Salvinorin A: Allosteric Interactions at the Mu-Opioid Receptor.
by Rothman RB, Murphy DL, Xu H, Godin JA, Dersch CM, Partilla JS, Tidgewell K, Schmidt M, Prisinzano TE.
Journal of Pharmacology and Experimental Therapeutics. 320(2): 801–810 (2007). This document is in PDF format.
|
Determination of Salvinorin A in Body Fluids by High Performance Liquid Chromatography-Atmospheric Pressure Chemical Ionization.
by Schmidt MS, Prisinzano TE, Tidgewell K, Harding W, Butelman ER, Kreek MJ, and Murry DJ.
Journal of Chromatography. B. 818(2): 221–225 (2005). This document is in PDF format.
|
Pharmacokinetics of the Plant-Derived Kappa-Opioid Hallucinogen Salvinorin A in Nonhuman Primates.
by Schmidt MD, Schmidt MS, Butelman ER, Harding WW, Tidgewell K, Murry DJ, Kreek MJ, Prisinzano TE.
Synapse. 58(3): 208–210 (2005). This document is in PDF format.
|
Psychopharmacology of the Hallucinogenic Sage Salvia divinorum.
by Prisinzano TE.
Life Sciences. 78(5): 527-531 (2005). This document is in PDF format.
|
Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Semisynthesis of Salvinicins A and B
and Other Chemical Transformations of Salvinorin A.
by Harding WW, Schmidt M, Tidgewell K, Kannan P, Holden KG, Gilmour B, Navarro H, Rothman RB, Prisinzano TE.
Journal of Natural Products. 69(1): 107–112 (2006). This document is in PDF format.
|
Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Selective Modification of the Furan Ring.
by Harding WW, Schmidt M, Tidgewell K, Kannan P, Holden KG, Dersch CM, Rothman RB, Prisinzano TE.
Bioorganic & Medicinal Chemistry Letters. 16(12): 3170–3174. This document is in PDF format.
|
Synthesis of Salvinorin A Analogues as Opioid Receptor Probes.
by Tidgewell K, Harding WW, Lozama A, Cobb H, Shah K, Kannan P, Dersch CM, Parrish D, Deschamps JR, Rothman RB, Prisinzano TE.
Journal of Natural Products. 69(6): 914–918 (2006). This document is in PDF format.
|
Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Preparation and Opioid Receptor Activity of Salvinicin Analogues.
by Simpson DS, Katavic PL, Lozama A, Harding WW, Parrish D, Deschamps JR, Dersch CM, Partilla JS, Rothman RB, Navarro H, Prisinzano TE.
Journal of Medicinal Chemistry. [ePublished ahead of print Jun 20, 2007]. This document is in PDF format.
|
Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Exploration of the 1-Position.
by Holden KG, Tidgewell K, Marquam A, Rothman RB, Navarro H, Prisinzano TE.
Bioorganic and Medicinal Chemistry Letters. 17(22): 6111–6115 (2008). This document is in PDF format.
|
Salvinorin A Analogs as Probes in Opioid Pharmacology.
by Prisinzano TE, Rothman RB.
Chemical Reviews. 108(5): 1732–1743. (2008). This document is in PDF format.
|
Herkinorin analogues with differential â-arrestin-2 interactions.
by Tidgewell K, Groer CE, Harding WW, Lozama A, Schmidt M, Marquam A, Hiemstra J, Partilla JS, Dersch CM, Rothman RB, Bohn LM, Prisinzano TE.
Journal of Medicinal Chemistry. 51(8): 2421–2431. (2008). This document is in PDF format.
|
Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors.
by Xu H, Wang X, Partilla JS, Bishop-Mathis K, Benaderet TS, Dersch CM, Simpson DS, Prisinzano TE, Rothman RB.
Brain Research Bulletin. 77(1): 49–54. (2008). This document is in PDF format.
|
The effects of herkinorin, the first ì-selective ligand from a salvinorin A-derived scaffold, in a neuroendocrine biomarker assay in non-human primates.
by Butelman ER, Rus S, Simpson DS, Wolf AK, Prisinzano TE, Kreek MJ.
The Journal of Pharmacology and Experimental Therapeutics. [ePubished ahead of print July 1, 2008]. This document is in PDF format.
|
Neo-clerodane Diterpenes from the Hallucinogenic Sage Salvia divinorum.
And errata. by Shirota O, Nagamatsu K, Sekita S.
Journal of Natural Products. 69(12): 1782–1786. (2006). This document is in PDF format.
|
Asymmetric Synthesis of Salvinorin A, a Potent Kaapa Opioid Receptor Agonist.
by Scheerer JR, Lawrence JF, Wang GC, Evans DA.
Supporting information here (4 MB file).
Journal of the American Chemical Society. [ePublished ahead of print June 30, 2007]. This document is in PDF format.
|
Total Synthesis of the Hallucinogenic Neoclerodane Diterpenoid Salvinorin A.
by Nozawa M, Suka Y, Hoshi T, Suzuki T, Hagiwara H.
Organic Letters. [ePublished ahead of print March 1, 2008]. This document is in PDF format.
|
Quantification of the Plant-Derived Hallucinogen Salvinorin A in Conventional and Non-Conventional Biological Fluids
by gas chromatography/mass spectrometry after Salvia divinorum smoking.
by Pichini S, Abanades S, Farre M, Pellegrini M, Marchei E, Pacifici R, Torre RD, and Zuccaro P.
Rapid Communications in Mass Spectrometry. 19(12): 1649–1656 (2005). This paper is in PDF format.
| |
Synthesis and In Vitro Pharmacological Evaluation of Salvinorin A Analogues Modified at C(2).
by Beguin C, Richards MR, Wang Y, Chen Y, Liu-Chen LY, Ma Z, Lee DY, Carlezon WA Jr, and Cohen BM.
Bioorganic and Medicinal Chemistry Letters. 15(11): 2761–2765 (2005). This document is in PDF format.
|
Synthesis and In Vitro Pharmacological Studies of New C(2) Modified Salvinorin A Analogues.
by Lee DY, Karnati VV, He M, Liu-Chen LY, Kondareti L, Ma Z, Wang Y, Chen Y, Beguin C, Carlezon WA Jr, Cohen B.
Bioorganic and Medicinal Chemistry Letters. 15(16): 3744–3747 (2005). This document is in PDF format.
|
Synthesis and In Vitro Pharmacological Studies of C(4) Modified Salvinorin A Analogues.
by Lee DY, He M, Kondaveti L, Liu-Chen LY, Ma Z, Wang Y, Chen Y, Li JG, Beguin C, Carlezon WA Jr, Cohen B.
Bioorganic and Medicinal Chemistry Letters. Jul 25, 2005 [Epub ahead of print]. This document is in PDF format.
|
New Neoclerodane Diterpenoids Isolated From the Leaves of Salvia divinorum and Their Binding Affinities for Human Kappa Opioid Receptors.
by Lee DY, Ma Z, Liu-Chen LY, Wang Y, Chen Y, Carlezon WA Jr, Cohen B.
Bioorganic and Medicinal Chemistry Letters. Aug 3, 2005 [Epub ahead of print]. This document is in PDF format.
|
Synthesis and In Vitro Pharmacological Studies of New C(4)-Modified Salvinorin A Analogues.
by Lee DY, He M, Liu-Chen LY, Wang Y, Li JG, Xu W, Ma Z, Carlezon WA Jr, Cohen B
Bioorganic and Medicinal Chemistry Letters. 16(21): 5498–5502 (2006). This document is in PDF format.
|
Depressive-like Effects of the Kappa-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats.
by Carlezon Jr WA, Beguin C, Dinieri JA, Baumann MH, Richards MR, Todtenkopf MS, Rothman RB, Ma Z, Lee DY, Cohen BM.
Journal of Pharmacology and Experimental Therapeutics. 316(1): 440–447 (2006). This document is in PDF format.
|
Synthesis and In Vitro Evaluation of Salvinorin A Analogues: Effect of Configuration at C(2) and Substitution at C(18).
by Beguin C, Richards MR, Li JG, Wang Y, Xu W, Liu-Chen LY, Carlezon WA Jr, Cohen BM.
Bioorganic and Medicinal Chemistry Letters. 16(17): 4679–4685 (2006). This document is in PDF format.
|
Revised Structure of Deacetyl-1,10-didehydrosalvinorin G.
by Ma Z, Lee DY.
Tetrahedron Letters. 48(31): 5461–5464 (2007). This document is in PDF format.
|
N-Methylacetamide Analogue of Salvinorin A: A Highly Potent and Selective Kappa Opioid Receptor Agonist with Oral Efficacy.
by Beguin C, Potter DN, Dinieri JA, Munro TA, Richards MR, Paine TA, Berry L, Zhao Z, Roth BL, Xu W, Liu-Chen LY, Carlezon Jr WA, Cohen BM.
The Journal of Pharmacology and Experimental Therapeutics. 324(1): 188–195 (2008). This document is in PDF format.
|
Exposure to the Selective Kappa-Opioid Receptor Agonist Salvinorin A Modulates the Behavioral and Molecular Effects of Cocaine in Rats.
by Chartoff EH, Potter D, Damez-Werno D, Cohen BM, Carlezon WA Jr
Neuropsychopharmacology. [Epub ahead of print Jan 9, 2008]. This paper is in PDF format.
|
Identification of the Molecular Mechanisms by Which the Diterpenoid Salvinorin A Binds to Kappa-Opioid Receptors.
by Yan F, Mosier PD, Westkaemper RB, Stewart J, Zjawiony JK, Vortherms TA, Sheffler DJ, Roth BL.
Biochemistry. 44(24): 8643–8651 (2005). This document is in PDF format.
|
Unambiguous NMR Spectral Assignments of Salvinorin A.
by Giner JL, Kiemle DJ, Kutrzeba L, Zjawiony J.
Magnetic Resonance in Chemistry. 45(4): 351–354 (2007). This document is in PDF format.
|
Biosynthesis of Salvinorin A Proceeds via The Deoxyxylulose Phosphate Pathway.
by Kutrzeba L, Dayan FE, Howell J, Feng J, Giner JL, Zjawiony JK.
Phytochemistry. 68(14): 1872–1881 (2007). This document is in PDF format.
|
Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and B.
by Bikbulatov RV, Yan F, Roth BL, Zjawiony JK.
Bioorganic and Medicinal Chemistry Letters. 17(8): 2229–2232 (2007). This document is in PDF format.
|
Short Synthesis of a Novel Class of Salvinorin A Analogs with Hemiacetalic Structure.
by Bikbulatov RV, Stewart J, Jin W, Yan F, Roth BL, Ferreira D, Zjawiony JK.
Tetrahedron Letters. 49: 937–940 (2008). This document is in PDF format.
|
Studies Towards the Synthesis of Salvinorin A.
by Lingham AR, Hügel HM, Rook TJ.
Australian Journal of Chemistry. 59(5): 340–348 (2006). This document is in PDF format.
|
Determination of Salvinorins and Divinatorins in Salvia divinorum Leaves by Liquid Chromatography/Multistage Mass Spectrometry.
by Medana C, Massolino C, Pazzi M, Baiocchi C.
Rapid Communications in Mass Spectrometry. 20(2): 131–136 (2005). This document is in PDF format.
|
Analysis of the Psychoactive Terpenoid Salvinorin A Content in Five Salvia divinorum Herbal Products.
by Wolowich WR, Perkins AM, Cienki JJ.
Pharmacotherapy. 26(9): 1268–1272(2006). This document is in PDF format.
|
Determination of Salvinorin A and Salvinorin B in Salvia divinorum-Related Products Circulated in Japan.
by Tsujikawa K, Kuwayama K, Miyaguchi H, Kanamori T, Iwata YT, Yoshida T, Inoue H.
Forensic Science International 180(2-3): 105-109 (2008). This document is in PDF format.
|
The Detection and Quantitative Analysis of the Psychoactive Component of Salvia divinorum, Salvinorin A,
in Human Biological Fluids Using Liquid Chromatography-Mass Spectrometry.
by McDonough PC, Holler JM, Vorce SP, Bosy TZ, Magluilo J Jr, Past MR.
Journal of Analytical Toxicology. 32(6): 417–421 (2008). This document is in PDF format.
|
The Antinociceptive Effect of Salvinorin A in Mice.
by Trentini, John F., Larry G. French, and Joseph S. Erlichman.
European Journal of Pharmacology. 545 (2–3): 129–133 (2006). This document is in PDF format.
|
Antinociceptive Profile of Salvinorin A, a Structurally Unique Kappa Opioid Receptor Agonist.
by McCurdy CR, Sufka KJ, Smith GH, Warnick JE, Nieto MJ.
Pharmacology, Biochemistry, and Behavior. [Epub ahead of print Jan 20, 2006]. This document is in PDF format.
|
A Unique Binding Epitope for Salvinorin A, a Non-Nitrogenous Kappa Opioid Receptor Agonist.
by Kane BE, Nieto MJ, McCurdy CR, Ferguson DM.
FEBS Journal. 273(9): 1966–1974 (2006). This document is in PDF format.
|
Toward a Structure-Based Model of Salvinorin A Recognition of the Kappa-Opioid Receptor.
by Kane BE, McCurdy CR, Ferguson DM.
Journal of Medicinal Chemestry. [ePublished ahead of print Feb 23, 2008]. This document is in PDF format.
|
A Combined Ligand-Based and Target-Based Drug Design Approach for G-Protein Coupled Receptors:
Application to Salvinorin A, a Selective Kappa Opioid Receptor Agonist.
by Singh N, Chevé G, Ferguson DM, McCurdy CR.
Journal of Computer-Aided Molecular Design. 20(7–8): 471–493 (2006). This document is in PDF format.
|
The Hallucinogen Derived from Salvia divinorum, Salvinorin A, has ê-Opioid Agonist Discriminative Stimulus Effects in Rats.
by Willmore-Fordham CB, Krall DM, McCurdy CR, Kinder DH.
Neuropharmacology. 53(4): 481–486 (2007). This document is in PDF format.
|
Discriminative Stimulus Effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in Rhesus Monkeys.
by Li JX, Rice KC, France CP.
The Journal of Pharmacology and Experimental Therapeutics. 324(2): 827–833 (2008). This document is in PDF format.
|
Intramolecular Diels-Alder/Tsuji Allylation Assembly of the Functionalized Trans-Decalin of Salvinorin A.
by Burns AC, Forsyth CJ.
Organic Letters. 10(1): 97–100 (2008). This document is in PDF format.
|
PCR and PCR-RFLP of the 5S-rRNA-NTS Region and Salvinorin A Analyses for the Rapid and Unequivocal Determination of Salvia divinorum.
by Bertea CM, Luciano P, Bossi S, Leoni F, Baiocchi C, Medana C, Azzolin CM, Temporale G, Lombardozzi MA, Maffei ME.
Phytochemistry. 67(4): 371–378 (2006). This document is in PDF format.
|
Authentication and Ultra Performance Liquid Chromatography (UPLC)/MS Analysis of Magic Mint, Salvia divinorum and Its Related Plants.
by Maruyama T, Kamakura H, Kikura-Hanajiri R, Goda Y.
Yakugaku Zasshi. 128(1): 179–183 (2008). This document is in PDF format.
|
Hallucinatory and Rewarding Effect of Salvinorin A in Zebrafish: Kappa-Opioid and CB1-Cannabinoid Receptor Involvement.
by Braida D, Limonta V, Pegorini S, Zani A, Guerini-Rocco C, Gori E, Sala M.
Psychopharmacology. 190(4): 441–448 (2007). This document is in PDF format.
|
Involvement of Kappa-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward.
by Braida D, Limonta V, Capurro V, Fadda P, Rubino T, Mascia P, Zani A, Gori E, Fratta W, Parolaro D, Sala M.
Biological Psychiatry. 63(3): 286–292 (2008). This document is in PDF format.
|
Opioid Receptors and Legal Highs: Salvia divinorum and Kratom.
by Babu KM, McCurdy CR, Boyer EW.
Clinical Toxicology (Philadelphia, PA). 46(2): 146–152 (2008). This document is in PDF format.
|
Ethnopharmacognosy and Human Pharmacology of Salvia divinorum and Salvinorin A.
by Jonathan Ott. Curare. 18(1): 103-129 (1995). |
Psychoactive Card IV. Salvia divinorum Epling et Játiva: Leaves of the Shepherdess.
by Jonathan Ott. Eleusis, n. 4, pp. 31-39, 1996. |
Scheda Psicoattiva IV. Salvia divinorum Epling et Játiva: Foglie della Pastora An Italian translation of the above. |
Dose-Response Effects of Salvinorin A on Basal Dopamine Levels in the Caudate Putamen of C57BL/6J Mice.
by Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ.
|
Effects of the Plant-Derived Hallucinogen Salvinorin A on Basal Dopamine Levels in the Caudate Putamen
and in a Conditioned Place Aversion Assay in Mice: Agonist Actions at Kappa Opioid Receptors.
by Yong Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ.
Psychopharmacology (Berl). 179(3): 551–558 (2005). This paper is in PDF format.
|
Pharmacokinetics of the Potent Hallucinogen, Salvinorin A in Primates Parallels the Rapid Onset and Short Duration of Effects in Humans.
by Hooker JM, Xu Y, Schiffer W, Shea C, Carter P, Fowler JS.
Neuroimage. ePublished ahead of print March 15, 2008. This paper is in PDF format.
|
Effects of Acute and Repeated Administration of Salvinorin A on Dopamine Function in the Rat Dorsal Striatum.
by Gehrke BJ, Chefer VI, Shippenberg TS.
Psychopharmacology (Berl). [ePublished ahead of print Feb 2, 2008]. This paper is in PDF format.
|
A Select Set of Opioid Ligands Induce Up-Regulation by Promoting the Maturation
and Stability of the Rat Kappa Opioid Receptor in Human Embryonic Kidney 293 Cells.
by Wannemacher KM, Yadav PN, Howells RD.
Journal of Pharmacology and Experimental Therapies. [Epub ahead of print Aug 24, 2007]. This paper is in PDF format.
|
Pharmacological Characterization of the Novel Kappa Opioid Agonist Salvinorin A in the Mouse
This study demonstrates that salvinorin A is active in vivo at kappa opioid receptors. |
The Rise of a New Psychoactive Agent: Salvia divinorum.
by Appel J, Kim-Appel D.
International Journal of Mental Health and Addiction. 5: 248–253 (2007). This paper is in PDF format.
|
Use of Salvia divinorum, an Unscheduled Hallucinogenic Plant: A Web-Based Survey of 500 Users.
This survey characterized the reasons, methods, and reported consequences of Salvia divinorum use. |
Pattern of Use and Subjective Effects of Salvia divinorum Among Recreational Users.
by González D, Riba J, Bouso JC, Gómez-Jarabo G, Barbanoj MJ.
Drug and Alcohol Dependence. 85(2): 157–162 (2006). This paper is in PDF format.
|
Salvia divinorum–Prësenz einer neuen
Droge im Internet. [Salvia divinorum—Representation of a New Drug in the Internet.]
[Abstract in English and German. Article in German only].
by Siemann H, Specka M, Schifano F, Deluca P, Scherbaum N.
Gesundheitswesen. 68(5): 323–327 (2006). This paper is in PDF format.
|
Internet Access to Salvia divinorum: Implications for Policy, Prevention, and Treatment.
by Hoover V, Marlowe DB, Patapis NS, Festinger DS, Forman RF.
Journal of Substance Abuse Treatment. 35(1): 22-27 (2008). This paper is in PDF format.
|
College Student Use of Salvia divinorum.
by Lange JE, Reed MB, Croff JM, Clapp JD.
Drug and Alcohol Dependence. 94(1-3): 263-266. This paper is in PDF format.
|
Legally High? Legal Considerations of Salvia divinorum.
by Griffin III OH, Miller BL, Khey DN.
Journal of Psychoactive Drugs. 40(2): 183-191 (2008).
|
Salvia divinorum Epling et Játiva-M. (Labiatae): An Ethnopharmacological Investigation.
by Sherry A. Rovinsky. McNair Scholarly Review (1998). |
Salvia divinorum: An Hallucinogenic Mint Which Might Become a New Recreational Drug in Switzerland.
Giroud et al. Forensic Science International. 112(2–3): 143–150 (2000). This paper is in PDF format.
|
Salvinorin: The Psychedelic Essence of Salvia divinorum. An extraordinary book by D.M.Turner (1996).
|
The Mushrooms of Language by Henry Munn. This essay provides valuable insight into the Mazatec shamanic world.
|
NovaScreen® receptor selectivity report on salvinorin-A. |
Sage Wisdom: Salvia divinorum Branches Out. by Robert Campbell. An article from TRP Magazine (1997). |
Cultivating Diviner's Sage by Will Beifuss. An article from TRP Magazine (1997). |
Under the Spell of the Magic Mint. by Christopher Ketcham. Published in GQ magazine. June, 2007. |
|

|
| Additional Information on Salvia divinorum and Related Topics |
Erowid - Salvia divinorum Vault. |
Lycaeum's Salvia Archives. |
Wikipedia article on Salvia divinorum. This webpage is continuously evolving. Anyone can participate in its development. |
Something from the Heffter Research Institute. |
USDA info on Salvia divinorum. |
Some basic information about Salvia divinorum. From the DEA's list of Drugs and Chemicals of Concern. |
A report on Salvia divinorum From the April 2003 edition of the Information Bulletin of the National Drug Intelligence Center.
Unfortunately, this document contains a lot of misinformation. It portrays all use of salvia as "abuse" and makes many false and inaccurate statements.
This report has been reprinted in the June 2003 edition of Microgram Bulletin (PDF format), a monthly newsletter
published by the U.S. Drug Enforcement Administration's Office of Forensic Sciences. |
Lagochilus inebrians. An intriguing psychoactive member of the Labiatae. |
Salvia splendens. A psychoactive sage??? |
|

|
| Relevant Organizations |
The Drug Policy Alliance. The leading organization working to broaden the public debate on drug policy and to promote realistic alternatives to the
war on drugs based on science, compassion, public health, and human rights. I strongly urge you to visit thier web site and make a generous financial
contribution to support the important work that this organization is doing. |
MAPS (The Multidisciplinary Association for Psychedelic Studies). Supporting psychedelic research since 1986. |
Erowid. The world's most comprehensive resource for information about psychoactive drugs.
We urge you to become a supporter. By joining or contributing, you can help ensure that this quality information remains freely available. |
The Center for Cognitive Liberty & Ethics (CCLE). A nonprofit education, law, and policy center working in the public interest to foster freedom
of thought. The CCLE has established the Salvia Divinorum Action Center and the Salvia Divinorum Defense Fund. |
The Council on Spiritual Practices. Dedicated to making direct experience of the sacred more available to more people. |
The Media Awareness Project. A worldwide network dedicated to drug policy reform. |
The Drug Reform Coordination Network. A national network of more than 21,000 activists and concerned citizens, including parents,
educators, students, lawyers, health care professionals, academics, and others working for drug policy reform.
DRCNet supports rational policies consistent with the principles of peace, justice, freedom,
compassion, and truth. Each of these has been compromised in the name of the Drug War.
|
Students for Sensible Drug Policy. Students for Sensible Drug Policy is committed to providing education on harms caused by the War on Drugs working
to involve youth in the political process, and promoting an open, honest, and rational discussion of alternative solutions to our nation's drug problems.
|
The American Civil Liberties Union. Useful drug policy links. |
|

|
| Mail Center |
I am always interested in hearing reports from people regarding their experiences with this herb. Click here to send me your thoughts, comments, experiences, and suggestions. I do read most of the email I receive; however, I receive more email than I have time to reply to. When replying to email, I give priority to correspondence that is particularly important or interesting.
Share this web site with a friend. This link opens a blank email window on most browsers. Please send your friends a note and let them know about The Salvia divinorum Research and Information Center. Don't forget to send them the URL: (http://sagewisdom.org). |

|
| Copyright © 1995-present, Daniel Siebert. All rights reserved. Use of any content of this site, for any purpose other than personal edification, is strictly forbidden without the expressed, written permission of the author. |
|
(This site was last updated on November 19, 2008)
|